Nanotechnology in cancer diagnosis: progress, challenges and opportunities
- PMID: 31847897
- PMCID: PMC6918551
- DOI: 10.1186/s13045-019-0833-3
Nanotechnology in cancer diagnosis: progress, challenges and opportunities
Abstract
In the fight against cancer, early detection is a key factor for successful treatment. However, the detection of cancer in the early stage has been hindered by the intrinsic limits of conventional cancer diagnostic methods. Nanotechnology provides high sensitivity, specificity, and multiplexed measurement capacity and has therefore been investigated for the detection of extracellular cancer biomarkers and cancer cells, as well as for in vivo imaging. This review summarizes the latest developments in nanotechnology applications for cancer diagnosis. In addition, the challenges in the translation of nanotechnology-based diagnostic methods into clinical applications are discussed.
Keywords: Cancer biomarker; Cancer diagnosis; Nanoparticle.
Figures
Similar articles
-
Nanotechnology enabling the use of circulating tumor cells (CTCs) as reliable cancer biomarkers.Adv Drug Deliv Rev. 2018 Feb 1;125:1-2. doi: 10.1016/j.addr.2018.04.014. Adv Drug Deliv Rev. 2018. PMID: 29880212 No abstract available.
-
Nanotechnology in Radiation Oncology.Hematol Oncol Clin North Am. 2019 Dec;33(6):1071-1093. doi: 10.1016/j.hoc.2019.08.002. Epub 2019 Oct 1. Hematol Oncol Clin North Am. 2019. PMID: 31668207 Free PMC article. Review.
-
Integration of biomimicry and nanotechnology for significantly improved detection of circulating tumor cells (CTCs).Adv Drug Deliv Rev. 2018 Feb 1;125:36-47. doi: 10.1016/j.addr.2017.12.005. Epub 2017 Dec 13. Adv Drug Deliv Rev. 2018. PMID: 29247765 Free PMC article. Review.
-
Nanotechnology for cancer diagnostics: promises and challenges.Expert Rev Mol Diagn. 2006 May;6(3):307-18. doi: 10.1586/14737159.6.3.307. Expert Rev Mol Diagn. 2006. PMID: 16706735 Review.
-
Nanotechnology for early cancer detection.Sensors (Basel). 2010;10(1):428-55. doi: 10.3390/s100100428. Epub 2010 Jan 6. Sensors (Basel). 2010. PMID: 22315549 Free PMC article.
Cited by
-
Synthesis, Characterization, and Antimicrobial and Antiproliferative Effects of CuO-TiO2-Chitosan-Escin Nanocomposites on Human Leukemic MOLT4 Cells.Nanomaterials (Basel). 2022 Oct 26;12(21):3753. doi: 10.3390/nano12213753. Nanomaterials (Basel). 2022. PMID: 36364538 Free PMC article.
-
Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer.Research (Wash D C). 2024 Jul 23;7:0429. doi: 10.34133/research.0429. eCollection 2024. Research (Wash D C). 2024. PMID: 39045421 Free PMC article. Review.
-
New prospects of cancer therapy based on pyroptosis and pyroptosis inducers.Apoptosis. 2024 Feb;29(1-2):66-85. doi: 10.1007/s10495-023-01906-5. Epub 2023 Nov 9. Apoptosis. 2024. PMID: 37943371 Review.
-
Nanomaterials for cancer therapy: current progress and perspectives.J Hematol Oncol. 2021 May 31;14(1):85. doi: 10.1186/s13045-021-01096-0. J Hematol Oncol. 2021. PMID: 34059100 Free PMC article. Review.
-
Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges.Pharmaceutics. 2023 Jun 10;15(6):1706. doi: 10.3390/pharmaceutics15061706. Pharmaceutics. 2023. PMID: 37376154 Free PMC article. Review.
References
-
- The, L., LANCET, (2018) 392, 985. - PubMed
-
- Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Cronin KA, Howlander N, Aminou R. Waldron. W. 2015.
-
- Rezaianzadeh A, Jalali M, Maghsoudi A, Mokhtari AM, Azgomi SH, Dehghani SL. Breast Dis. 2017;37:1. - PubMed
-
- Listed N. Dukemed Healthnews. 2010;16:8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical